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ownstream of kinase (Dok)–related protein (DokR,
also known as p56
 
dok
 
/FRIP/Dok-R) is implicated in
cytokine and immunoreceptor signaling in myeloid
and T cells. Tyrosine phosphorylation induces DokR to
bind the signal relay molecules, RasGTPase-activating protein
(RasGAP) and Nck. Here, we have examined the function of
DokR during hematopoietic development and the require-
ment for RasGAP and Nck binding sites in its biological
function. Retroviral-mediated expression of DokR in bone
marrow cells dramatically inhibited their capacity to form
colonies in vitro in response to the cytokines macrophage
colony–stimulating factor and stem cell factor, whereas
responses to interleukin-3 and granulocyte macrophage
D
 
colony–stimulating factor were only weakly affected.
When introduced into lethally irradiated mice, hematopoietic
 
cells expressing DokR showed a drastically reduced capacity
 
to repopulate lymphoid tissues. Most notably, DokR
dramatically reduced repopulation of the thymus, in part
by reducing the number of T cell precursors seeding in the
thymus, but equally, through inhibiting the transition of
 
CD4
 
 
 
CD8
 
 
 
 to CD4
 
 
 
CD8
 
 
 
 T cells. Consequently, the number
of mature peripheral T cells was markedly reduced. In
contrast, a minimal effect on B cell and myeloid lineage
development was observed. Importantly, functional RasGAP
and Nck binding sites were found to be essential for the
biological effects of DokR in vitro and in vivo.
 
Introduction
 
The downstream of kinase (Dok)* proteins are a recently
 
described family of docking molecules that interact in a
tyrosine phosphorylation–dependent manner with a range
of intracellular signaling molecules (Tomlinson et al., 2000).
 
Five Dok family molecules have been described: p62
 
dok
 
,
otherwise known as Dok1 (Carpino et al., 1997; Yamanashi
and Baltimore, 1997); p56
 
dok
 
/FRIP/Dok-related protein
(DokR) (Di Cristofano et al., 1998; Jones and Dumont,
1998; Nelms et al., 1998; Lock et al., 1999); DOKL/Dok-3
(Cong et al., 1999; Lemay et al., 2000); Dok-4; and Dok-5
(Grimm et al., 2001). Dok proteins contain a pleckstrin ho-
mology domain, a phosphotyrosine binding domain, and a
COOH-terminal region containing multiple tyrosine phos-
phorylation sites. These proteins are implicated in the regu-
lation of multiple biological processes, including cell prolif-
eration (Suzu et al., 2000; Yamanashi et al., 2000; Di
Cristofano et al., 2001), transformation and tumorigenesis
(Cong et al., 1999; Di Cristofano et al., 2001; Songyang et
al., 2001), cell motility (Noguchi et al., 1999; Hosooka et
al., 2001; Master et al., 2001), and differentiation (Grimm
et al., 2001).
DokR is expressed in adult and embryonic hematopoietic
tissues including thymus, lymph node, spleen, and fetal liver
(Di Cristofano et al., 1998; Nelms et al., 1998; Lock et al.,
1999; Lemay et al., 2000; Grimm et al., 2001). Several he-
matopoietic lineages, including T cells, macrophages, mast
cells, and hematopoietic stem cells, express DokR (Nelms et
al., 1998; Lemay et al., 2000; Phillips et al., 2000; Suzu et
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al., 2000), whereas B cells appear to lack detectable levels of
DokR (Nelms et al., 1998; Lemay et al., 2000). Intriguingly,
DokR mRNA and protein levels increase rapidly in NFS-60
myeloid leukemia cells and in primary macrophages stimu-
lated with macrophage colony–stimulating factor (M-CSF),
implying a role for DokR as a feedback regulatory molecule
(Suzu et al., 2000).
Cytokines such as M-CSF (Suzu et al., 2000), stem cell
factor (SCF) (Wisniewski et al., 1996), and interleukin (IL)-4
(Nelms et al., 1998) have been shown to rapidly induce the
tyrosine phosphorylation of endogenous DokR in myeloid
cells, whereas cross-linking antibodies to various immunore-
ceptors, such as CD2 (Nemorin and Duplay, 2000) and sig-
naling lymphocyte activation molecule (SLAM) (Latour et
al., 2001), promote DokR tyrosine phosphorylation in T
cells. DokR is therefore likely to be a common component
in several tyrosine kinase–mediated signaling cascades in
these hematopoietic lineages.
Once tyrosine phosphorylated, DokR binds to RasGTP-
ase-activating protein (RasGAP) and Nck (Di Cristofano et
al., 1998; Jones and Dumont, 1998, 1999; Nelms et al.,
1998; Lock et al., 1999). We and others have shown previ-
ously that these interactions are mediated by tyrosine-phos-
phorylated YxxP motifs located in the COOH terminus of
DokR and by SH2 domains in RasGAP and Nck (Di Cris-
tofano et al., 1998; Nelms et al., 1998; Jones and Dumont,
1999; Lock et al., 1999). Specifically, Y351 of DokR is re-
sponsible for interaction with Nck, whereas Y276 and Y304
in combination mediate binding to RasGAP. The RasGAP
protein is implicated as a negative regulator of Ras, as it is
capable of stimulating the intrinsic GTPase activity of Ras,
thereby converting it into an inactive GDP-bound form
(Boguski and McCormick, 1993). The Nck protein is an
adaptor molecule containing three SH3 domains followed
by an SH2 domain, and is implicated in cytoskeletal regula-
tion (McCarty, 1998).
Recent evidence suggests that DokR participates in signal-
ing pathways that suppress cell proliferation. When overex-
pressed, DokR inhibits the proliferation of NFS-60 myeloid
leukemia cells stimulated with cytokines, whereas overex-
pression of antisense DokR constructs enhances the growth
of J774 cells (Suzu et al., 2000). The DokR gene has been
mapped to the 
 
hairless
 
 (
 
hr
 
) locus on chromosome 14 (Nelms
et al., 1998). This locus also contains the gene for a putative
transcription factor (Cachon-Gonzalez et al., 1994). Inter-
estingly, DokR levels are reduced in several hematopoietic
cell types from 
 
hairless
 
 mice (Nelms et al., 1998; Suzu et al.,
2000). Analysis of peripheral T cells from these mice showed
that they are hyperresponsive to cytokine and T cell receptor
(TCR) stimulation (Nelms et al., 1998), while macrophage
numbers in these mice are modestly elevated (Suzu et al.,
2000). Although these studies support a role for DokR in
the negative regulation of cellular proliferation, the require-
ment for DokR interactions with Nck and RasGAP in medi-
ating these effects has not been investigated. Moreover, the
role of DokR in vivo remains unclear, as the involvement of
genes such as the 
 
hr
 
 gene in causing the phenotype of 
 
hairless
 
mice is not known.
In the following study, we explore the physiological role
of DokR in hematopoiesis. We demonstrate that constitu-
 
tive expression of DokR in bone marrow cells differentially
inhibits cytokine-dependent proliferation of progenitor cells
in vitro and selectively inhibits early T cell development in re-
constituted mice, suppressing both the seeding of the thymus
and the progression of thymocytes from the CD4
 
 
 
CD8
 
 
 
 to
the CD4
 
 
 
CD8
 
 
 
 stage, resulting in a marked decrease in
peripheral T cells. Furthermore, both RasGAP and Nck
are implicated in mediating the biological activity of
DokR, as no inhibitory activity in vitro or in vivo was ob-
served with DokR mutants deficient in binding sites for ei-
ther protein.
Figure 1. Retrovirus-mediated expression of FLAG–DokR proteins 
in murine bone marrow cells. (A) Schematic representation of 
FLAG–DokR and mutants thereof showing the location of tyrosine 
(Y) to phenylalanine (F) substitutions. The ability ( ) or inability ( ) 
of the DokR proteins to bind RasGAP and Nck is indicated (also see 
E). (B) Diagram of pMY-EGFP, the bicistronic retroviral vector used 
to express FLAG–DokR proteins. The viral long terminal repeats 
(LTR), extended packaging signal (  ), multiple cloning site (MCS), 
IRES, and enhanced GFP (eGFP) cassette are indicated. (C) Flow 
cytometric analysis of bone marrow cells 7 d after infection with the 
indicated retroviral constructs, showing the percentages of GFP
  
(top) and GFP
 /cKit
  cells (bottom). (D) Expression of retrovirally 
expressed FLAG–DokR proteins in bone marrow cells was examined 
by immunoprecipitation (IP) with an anti-FLAG antibody and Western 
blot (WB) analysis with an anti-DokR serum. (E) 293T cells were 
transfected with pMY-IRES–GFP retroviral vectors encoding Y351F 
or Y276/304F together with a pEF-BOS vector encoding Lyn. Cell 
lysates were analyzed 48 h after transfection by immunoprecipitation 
with anti-FLAG antibody and Western blotting with anti-GAP, anti-
Nck, and anti-DokR sera. As a control, samples of whole cell lysate 
(WCL), containing 5% of the protein that was analyzed by IP, were 
probed with anti-GAP and anti-Nck. 
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Results
 
DokR selectively inhibits cytokine-dependent colony 
formation by hematopoietic progenitor cells
 
To study the role of DokR in primary hematopoietic cells,
cDNAs encoding FLAG-tagged DokR or the FLAG–DokR
mutants, Y351F and Y276/304F, shown previously to lack
functional binding sites for Nck and RasGAP, respectively
(Jones and Dumont, 1998, 1999; Lock et al., 1999; Fig. 1
A), were inserted into the retroviral vector pMY-EGFP
(Onai et al., 2000; Fig. 1 B). This bicistronic vector is capa-
ble of driving transcription in a wide range of hematopoietic
lineages (Onai et al., 2000), and contains an internal riboso-
mal entry site (IRES) and the gene encoding green fluores-
cent protein (GFP), enabling cells expressing DokR (or mu-
tant thereof) to be detected by GFP fluorescence. High-titre
stocks of the control (empty) retrovirus and those encoding
the different forms of FLAG–DokR were generated by trans-
fection of Bosc23 virus–producing cells (Pear et al., 1993).
Bone marrow cells from C57BL/6 mice treated with 5-fluor-
ouracil (to enrich for immature hematopoietic cells) were se-
rially infected with equivalent numbers of the different retro-
viruses. As shown in Fig. 1 C, flow cytometric analysis of the
cells 7 d after infection revealed that all four retroviruses had
a similar infection capability, as judged by the similar frac-
tions of GFP
 
 
 
 cells generated. Notably, although infection
efficiency varied between experiments, in any given experi-
ment each retrovirus infected a comparable number of cells
(unpublished data). Immunofluorescent staining of bone
marrow cells showed that a significant proportion of infected
(GFP
 
 
 
) as well as noninfected cells expressed c-Kit (Fig. 1
C), a marker found mainly on immature cells, but also on
mast cells. Cytospin analysis of infected cells revealed that
 
 
 
0.5% of cells were mast cells, whereas the majority of cells
were immature myeloid cells, including blasts (40–46%) and
promyelocytes (27–35%). Less than 9% of cells had differen-
tiated into neutrophils (2–5%), eosinophils (1–2%), or mac-
rophages (1–2.5%) (unpublished data). We could detect no
clear differences in the proportions of these cell types in bone
marrow infected with the various retroviruses. Immunopre-
cipitation analysis with a FLAG antibody and immunoblot
analysis with DokR-specific antiserum confirmed that the
bone marrow cells expressed the wild-type and mutant
FLAG–DokR proteins (Fig. 1 D).
We were interested in confirming the binding specificity
of the retrovirus vector–encoded FLAG–DokR mutants.
Retroviral constructs encoding Y351F and Y276/304F were
therefore introduced into 293T cells with the Src kinase,
Lyn, to induce DokR tyrosine phosphorylation. Immuno-
precipitation analysis of the DokR mutants (Fig. 1 E) clearly
demonstrated that the Y351F mutant binds selectively to
RasGAP and, conversely, the Y276/304F mutant binds se-
lectively to Nck, confirming our previous analysis of these
mutants (Lock et al., 1999). Our results do not exclude the
possibility that the Y351 and Y276/Y304 docking sites
could also mediate binding to unknown proteins besides
RasGAP and Nck. We also tried to demonstrate FLAG–
DokR interactions in virus-infected bone marrow cells that
were treated with pervanadate to enhance cellular tyrosine
phosphorylation and SH2-dependent interactions (Harder
et al., 2001). However, we were unable to detect interaction
of wild-type or mutant FLAG–DokR proteins with RasGAP
or Nck in these cells, presumably because we had only low
numbers of cells for analysis, the endogenous levels of Ras-
GAP and Nck were too low for detection by the antibodies
used, and/or these interactions may normally only occur in a
small fraction of the total cells. Consistent with the latter
possibility, the biological effects of DokR that we observed
in in vitro colony formation assays (Fig. 2) were apparent
only in a minor fraction of cells.
To assess the effects of retrovirus-mediated expression of
DokR in primary hematopoietic progenitor cells, nonin-
fected bone marrow cells or cells infected with the various
retroviruses were subjected to in vitro colony formation as-
says in the presence of SCF, IL-3, granulocyte macrophage
colony–stimulating factor (GM-CSF), or M-CSF. Cells in-
fected with the control (empty) virus and noninfected cells
formed equivalent numbers of colonies in each of the cyto-
kines tested (unpublished data), indicating that the infection
procedure per se did not affect colony forming ability. On
the other hand, Fig. 2 shows that bone marrow cells infected
with the DokR-encoding retrovirus formed fewer GFP
 
 
 
 col-
onies than control virus–infected cells in response to each
cytokine, but the extent of this reduction varied dramati-
cally. For instance, DokR virus–infected cells formed 35-
fold fewer colonies than control virus–infected cells when
cultured in the presence of M-CSF, whereas a fourfold re-
duction was observed in the presence of SCF and less than
twofold reductions were observed with IL-3 and GM-CSF.
In contrast, cells infected with viruses encoding the DokR
mutants, Y351F and Y276/304F, formed similar or in some
cases significantly greater colony numbers than control vi-
rus–infected cells (Fig. 2). These results imply that M-CSF
and SCF signaling in hematopoietic progenitor cells is pref-
erentially inhibited by enforced expression of DokR, and
that tyrosines Y351 (which mediates binding to Nck) and
Figure 2. Retrovirus-mediated expression of FLAG–DokR but not 
DokR mutants in bone marrow cells differentially suppresses
cytokine-dependent proliferation in vitro. Graphs show the numbers 
of GFP
  colonies formed by bone marrow cells infected with the 
indicated retroviral constructs and stimulated with the indicated 
cytokines. Numbers are the arithmetic means   SEM of quadruplicate 
determinations in three independent experiments. *P   0.05, **P   
0.01, and ***P   0.001, compared with control (empty) retrovirus-
infected cells (t test). 
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Y276 and Y304 (which mediate RasGAP binding) are essen-
tial for its growth inhibitory activity.
 
Enforced expression of DokR in bone marrow cells 
suppresses reconstitution of lymphoid tissues 
in lethally irradiated mice
 
To explore the role of DokR in vivo, we compared the abil-
ity of bone marrow cells infected with the control, DokR,
Y351F, or Y276/304F retroviruses to reconstitute hemato-
poiesis in lethally irradiated mice. For simplicity, reconsti-
tuted animals will be referred to as control, DokR, Y351F,
or Y276/304F mice, respectively. 10 wk after reconstitution,
the spleens, thymi, and bone marrow of reconstituted mice
were collected and the cellularity of each tissue was deter-
mined. Table I shows that the total numbers of thymocytes
and bone marrow cells (including GFP
 
 
 
 and GFP
 
 
 
 cells)
did not differ significantly between the different classes of
reconstituted mice, whereas the Y351F and Y276/304F
mice contained about twofold greater numbers of spleno-
cytes than control mice. This increased cellularity appears to
be related to reconstitution efficiency rather than to a direct
effect of the DokR mutant proteins Y351F or Y276/304F,
as the numbers of both GFP
 
 
 
 as well as GFP
 
 
 
 splenocytes
are increased (Table I; unpublished data).
Comparison of the proportion of leukocytes expressing
GFP in control and DokR mice revealed that an average of
45% of bone marrow cells, 46% of splenocytes, and 48% of
thymocytes were GFP
 
 
 
 in the control mice (Fig. 3 A; Table
I), whereas only 
 
 
 
24, 14, and 7% of the respective cell types
were GFP
 
 
 
 in DokR mice (Table I; Fig. 3 A). The reduced
percentage of GFP
 
 
 
 splenocytes and thymocytes, but not
bone marrow cells, in DokR mice was highly statistically sig-
nificant. In contrast, the percentages of these cells in Y351F
and Y276/304F mice were not significantly different to
those observed for the control mice (Fig. 3 A; Table I).
Quantitation of the absolute numbers of GFP
 
 
 
 cells in re-
constituted mice revealed that DokR mice contained about
threefold fewer GFP
 
 
 
 splenocytes and nearly 20-fold fewer
GFP
 
 
 
 thymocytes than control mice (Table I), whereas
Y351F and Y276/304F mice contained slightly more GFP
 
 
 
splenocytes and slightly fewer thymocytes than the control
mice (Table I). Collectively, these results provide evidence
that the capacity of hematopoietic precursor cells to repopu-
late the spleens and, even more dramatically, the thymi of ir-
radiated mice was suppressed by enforced expression of
DokR. These results also implicate the tyrosine phosphory-
lation sites that mediate binding of DokR to RasGAP and
Nck as critical determinants of its biological activity.
The thymi in a minority (
 
 
 
20%) of DokR mice con-
tained a relatively high percentage (up to 48%) of GFP
 
 
 
thymocytes but, strikingly, most of these cells expressed a
relatively low level of GFP (GFP
 
lo
 
 is henceforth arbitrarily
defined as 
 
 
 
10
 
3
 
 log
 
10
 
 fluorescence units) (Fig. 3 B), whereas
the vast majority of thymocytes from control, Y351F, or
Y276/304F mice expressed GFP at high levels (GFP
 
hi
 
, 
 
 
 
10
 
3
 
log
 
10
 
 fluorescence units) (Fig. 3 A; unpublished data). Com-
parison of the absolute numbers of GFP
 
hi
 
 cells in reconsti-
tuted mice revealed that, on average, the thymi of DokR
mice contained 
 
 
 
110-fold fewer GFP
 
hi
 
 cells than control
mice (Table I), whereas Y351F and Y276/304F mice con-
tained less than twofold fewer GFP
 
hi
 
 thymocytes than con-
trol mice (Table I). Similarly, the spleens of DokR mice
contained about eightfold fewer GFP
 
hi
 
 cells than the control
mice, whereas the number of GFP
 
hi
 
 cells in the spleens of
 
Table I. 
 
DokR suppresses the capacity of bone marrow cells to repopulate lymphoid tissues in irradiated mice
Tissue Group
 
n
 
Number of leukocytes
 
a
 
GFP
 
 
 
 leukocytes
 
b
 
GFP
 
hi
 
 leukocytes
 
c
 
Number of GFP
 
 
 
 
leukocytes
 
d
 
Number of GFP
 
hi
 
 
leukocytes
 
d
 
 
 
10
 
6
 
%%
 
 
 
10
 
6
 
 
 
10
 
6
 
Spleen
Control 18 126 
 
 
 
 22 46 
 
 
 
 5 28 
 
 
 
 4 54 
 
 
 
 11 35 
 
 
 
 9
DokR 17 106 
 
 
 
 20 14 
 
 
 
 4
 
g
 
3.5 
 
 
 
 1.3
 
g
 
16 
 
 
 
 6
 
e
 
4.2 
 
 
 
 1.9
 
f
 
Y351F 7 272 
 
 
 
 30
 
f
 
35 
 
 
 
 5 17 
 
 
 
 4 93 
 
 
 
 14 45 
 
 
 
 9
Y276/304F 9 212 
 
 
 
 39
 
e
 
41 
 
 
 
 7 21 
 
 
 
 4 78 
 
 
 
 20 46 
 
 
 
 15
Thymus
Control 18 104 
 
  11 48   9 45   9 47   10 43   10
DokR 17 75   10 7   3
g 1.2   0.5
g 2.4   1
g 0.4   0.1
g
Y351F 7 111   28 40   12 31   13 36   13 31   14
Y276/304F 9 74   17 52   14 44   13 32   11 29   10
Bone marrow
Control 16 34   4 45   8 33   6 15   3 10   2
DokR 16 34   3 24   7 17   58    36    2
Y351F 4 35   2 37   15 23   9 12   4 11   3
Y276/304F 6 41   7 32   11 22   9 16   9 11   6
Splenocytes, thymocytes and bone marrow cells from the femurs of mice were harvested 10 wk after reconstitution with bone marrow cells infected with
the indicated retroviral constructs. All values are the arithmetic means   SEM of determinations from up to 18 animals per experimental group (see n values).
P values were determined using an unpaired t test and are based on comparisons of the indicated data with corresponding control data.
aLeukocyte numbers (GFP
  plus GFP
  cells) were determined hemocytometrically after RBC lysis. 
bThe percentage of GFP
  leukocytes was determined by flow cytometry. 
cGFP
hi is defined as  103 log10 fluorescence units.
dNumbers of GFP
  and GFP
hi leukocytes were determined by multiplying the percentage of GFP
  or GFP
hi cells by the total cell number.
eP   0.05.
fP   0.01.
gP   0.001.DokR negatively regulates T cell development | Gugasyan et al. 119
Y351F and Y276/304F mice was slightly greater than that in
control mice (Table I). These results suggest that the ability
of DokR to inhibit repopulation of the thymus and the
spleen is concentration dependent.
To assess whether the levels of GFP measured by flow cy-
tometry accurately represented the levels of FLAG–DokR
proteins in cells, splenocytes and thymocytes from reconsti-
tuted mice were analyzed by immunoprecipitation with an
anti-FLAG antibody and immunoblotting with an anti-
DokR serum (Fig. 3 C). As expected, FLAG–DokR proteins
were not detected in splenocytes or thymocytes from control
mice or nonreconstituted C57BL/6 mice. However, wild-
type and mutant forms of FLAG–DokR were detected in
both cell types at a range of levels that correlated well with
the percentage of GFP
lo and GFP
hi cells in the individual
samples (Fig. 3 C). Notably, the levels of wild-type FLAG–
DokR in thymocytes from DokR mice were much lower
than those of DokR mutant proteins in Y351F and Y276/
304F mice (Fig. 3 C; unpublished data), in agreement with
our finding that thymi from DokR mice contained a signifi-
cantly lower proportion of GFP
  cells than Y351F or Y276/
Figure 3. Retrovirus-mediated expression of FLAG–DokR but not 
DokR mutants inhibits the ability of bone marrow cells to repopulate 
lymphoid tissues in irradiated mice. (A) Flow cytometric analysis of 
splenocytes and thymocytes from reconstituted mice. Animals were 
reconstituted with bone marrow cells that had been infected in vitro 
with the indicated retroviral constructs. The histograms shown are 
representative of data obtained from 7 to 18 mice per reconstitution 
group. The percentage of GFP
  cells of each cell type is indicated 
(Table I). (B) Flow cytometric analysis of thymocytes from two mice 
reconstituted with bone marrow cells infected with the DokR-
expressing retrovirus. These data are representative of a minority 
of DokR mice (3 out of 17) that contained  6% GFP
  cells. The 
percentages of GFP
lo (defined arbitrarily as  10
3 log10 fluorescence 
units) and GFP
hi cells ( 10
3 log10 fluorescence units) are indicated. 
(C) Expression of retrovirus-encoded FLAG–DokR proteins in 
splenocytes and thymocytes of reconstituted mice was assessed by 
immunoprecipitation (IP) with anti-FLAG antibodies and Western 
blot (WB) analysis with an anti-DokR serum. The percentage of 
GFP
lo and GFP
hi cells (see legend in B) in each sample is indicated.
Figure 4. Constitutive expression of DokR suppresses CD4
 CD8
  to 
CD4
 CD8
  thymocyte progression. (A) Flow cytometric analysis 
showing the expression of CD4 and CD8 (detected by immunofluores-
cent staining with tricolor- and PE-conjugated antibodies, respectively) 
on GFP
  thymocytes from reconstituted mice. The percentage of 
GFP
  thymocytes of each thymic subset is indicated. Dot plots 
shown are representative of data corresponding to between 7 and 
13 mice per reconstitution group. (B) Bar graphs showing the 
absolute numbers of GFP
  thymocytes of the indicated thymocyte 
subsets in groups of reconstituted mice. These figures were calculated 
by determining the proportion of GFP
  thymocytes of each subset 
by immunofluorescence staining and flow cytometry and multi-
plication by the total thymocyte number (Table I). The data represent 
the arithmetic means   SEM of determinations from n   7 to n   13 
mice per group of reconstituted mice. *P   0.05 and **P   0.01, 
compared with control retrovirus–infected cells (unpaired t test).120 The Journal of Cell Biology | Volume 158, Number 1, 2002
304F mice (Table I). Importantly, thymocytes from DokR
mice containing a relatively high percentage of GFP
lo cells
(e.g., Fig. 3 C, lane 4) were also found to contain very little
FLAG–DokR protein, confirming that GFP levels closely
reflected cellular FLAG–DokR protein levels.
Retrovirus-mediated expression of DokR suppresses 
seeding of the thymus and thymocyte maturation
The most dramatic effect of DokR was its ability to inhibit
repopulation of the thymus (Table I). This could be due to
reduced numbers of thymocyte precursors, inhibition of mi-
gration of thymocyte precursors to the thymus, and/or matu-
ration of thymocyte precursors into the more abundant ma-
ture thymocyte populations. To examine more carefully the
effect of DokR on thymic repopulation, thymocytes from re-
constituted mice were stained with immunofluorescent anti-
bodies to CD4 and CD8 and analyzed by flow cytometry.
Although the number of total thymic GFP
  cells was dra-
matically reduced in DokR mice, we were nevertheless able
to detect GFP
  thymocytes corresponding to each of the four
major classes of thymic T cells, including CD4
 CD8
  dou-
ble negative (DN) cells (including pro–T cells), CD4
 CD8
 
double positive (DP) cells (immature T cells), and CD4
  and
CD8
  single positive (SP) cells (representing mature T cells)
(Fig. 4 A). Interestingly however, the percentage of GFP
 
cells of the DN phenotype was  4.5-fold higher in DokR
mice compared with control mice and up to sevenfold higher
than in DokR mutant mice (Fig. 4 A; unpublished data). By
contrast, the percentage of GFP
  DP cells in DokR mice was
consistently  20% lower than in control, Y351F, and Y276/
304F mice (Fig. 4 A; unpublished data).
Because the total numbers of GFP
  thymocytes in DokR
mice were dramatically reduced (Table I), we were interested
in knowing what the effect of DokR was on the absolute
numbers of GFP
  cells at each stage of development (Fig. 4
B). Also, although the fraction of GFP
  cells that were DN
was significantly increased in DokR mice, these cells nor-
mally represent only a minor population and their relative
proportion could easily be affected by changes in the fre-
quencies of other thymocyte populations. Indeed, analysis of
absolute numbers demonstrated that, on average, DokR
mice had similar total numbers of GFP
  DN cells to the
other classes of reconstituted mice (Fig. 4 B, see legend). By
contrast, however, there were about eightfold fewer GFP
 
DP thymocytes in DokR mice than the control mice. Be-
cause these cells normally account for  80% of total thy-
mocytes, it is their reduced numbers in DokR mice that is
primarily responsible for the marked reduction in total
GFP
  thymocytes. In parallel with this, DokR mice also
contained six- to sevenfold fewer mature GFP
  SP thy-
mocytes compared with the control mice. In the Y351F and
Y276/304F mice, the numbers of GFP
  thymocytes of each
subtype were not significantly different from those in the
control mice.
Because DN cells can include cells of non–T cell lineages,
such as B cells, NK cells, dendritic cells, and myeloid cells, we
wanted to exclude these non–T cells from our analysis. To do
this, all cells expressing the markers Gr-1, Mac-1, B220, and
MHC class II, as well as T cells expressing CD4 and CD8
were eliminated by cell sorting. The remaining DN T cell
precursors were then examined by flow cytometry for expres-
sion of GFP. Fig. 5 shows that a high proportion (on average
20%) of the resulting DN T cell precursors derived from
DokR mice were GFP
 , confirming that DokR-expressing
thymocyte precursors are generated in the bone marrow and
are able to migrate to the thymus. Nevertheless, the propor-
tion of GFP
  cells was approximately two- to threefold
higher in the control mice, suggesting that DokR partially in-
hibits the generation of these cells from infected bone mar-
row cells or suppresses their ability to migrate into the thy-
mus. However, because the total numbers of immature (DP)
and mature (SP) thymocytes were more dramatically reduced
(by up to eightfold; Fig. 4 B), DokR also clearly inhibits pro-
gression of DN T cells into more mature T cells. Collectively
these results suggest that DokR inhibits repopulation of the
thymus in two ways; first by inhibiting the seeding of the
thymus with T cell precursors, either by inhibiting their for-
mation or their migration to the thymus and, second, by in-
hibiting their maturation from DN T cell precursors into DP
T cells. Furthermore, the activity of DokR is dependent on
both its RasGAP and Nck binding sites.
DokR selectively inhibits T lymphoid development
Mature T lymphocytes leave the thymus and migrate to pe-
ripheral lymphoid tissues, such as the spleen and lymph
nodes. To assess the effects of DokR on peripheral T cells,
splenocytes were stained with antibodies to CD4 and CD8
and analyzed by flow cytometry. Consistent with the greatly
reduced numbers of GFP
  SP T cells in the thymi of DokR
mice (Fig. 4 B), we found that the frequency of GFP
  sple-
nocytes expressing CD4 or CD8 in DokR mice (Fig. 6 A,
bottom) was substantially lower than in the control or the
DokR mutant mice. By contrast, the percentage of CD4
  or
CD8
  cells derived from GFP
  (noninfected) precursor cells
was similar in DokR mice to that in control and DokR mu-
tant mice (Fig. 6 A, top). In absolute terms, the spleens of
DokR mice contained about eightfold fewer GFP
  T cells
than control mice (unpublished data). An increase in the to-
tal numbers of GFP
  splenic T cells in the mutant mice was
observed, suggesting a possible dominant negative effect, al-
Figure 5. DokR partially suppresses seeding of the thymus by T 
cell precursors. Representative histograms showing flow cytometric 
analysis of thymic T cell precursors from control and DokR mice 
(n   4 for each class of mice). The cells analyzed were prepared by 
sorting for cells that lacked surface expression of the following 
lineage markers: CD4, CD8, MHC class II, B220, Gr-1, and Mac-1 
(see Materials and methods). The percentage of GFP
  cells is indicated.DokR negatively regulates T cell development | Gugasyan et al. 121
though the significance of this finding is unclear, as, overall,
the total splenic cellularity (including GFP
  cells) was also
increased (Table I).
The decreased percentage of GFP
  splenic T cells in the
DokR mice was accompanied by a small corresponding in-
crease in the percentage of GFP
  B cells (Fig. 6 B). Despite
this, a small reduction (approximately twofold) in the total
numbers of GFP
  splenic B cells in DokR mice was ob-
served, but this was not found to be significant (unpublished
data). No significant differences were observed in the total
numbers of splenic B cells for the four groups of reconsti-
tuted mice (unpublished data). These results suggest that
constitutive expression of DokR in bone marrow cells does
not greatly affect B cell development in vivo.
Our in vitro colony assay data showing inhibition of M-CSF–
and SCF-dependent colony formation by DokR (Fig. 2) sug-
gested that DokR might affect myeloid lineage development
in vivo. Surprisingly, however, DokR mice showed only a
slight reduction (although not significant) in the percentage of
GFP
  bone marrow cells (which contain a high proportion of
myeloid cells) compared with control mice (Table I). More-
over, as shown in Fig. 7 A, analysis of GFP
  cells from recon-
stituted mice revealed that similar percentages of these cells
were of a myeloid (Gr-1
  and Mac-1
  cells) or erythroid lin-
eage (Ter-119
  cells) in control and DokR mice.
Although the bone marrow analysis suggested a minimal
effect of DokR on myeloid lineages, we were interested in
knowing whether these results were reflected in myeloid lin-
eages from other hematopoietic compartments. We therefore
analyzed leukocytes from the blood of control and DokR
mice for expression of GFP, Gr-1, and Mac-1. Here, we
again observed a small, but in this case significant (greater
than twofold), reduction in the percentage of GFP
  cells in
DokR mice versus control mice (33   4% vs. 14   2%, re-
spectively; unpublished data). Analysis of the GFP
  cells
shows that the percentages of Gr-1
 /Mac-1
  (monocytes)
and Gr-1
 /Mac-1
  cells (neutrophils) were approximately
two- to fourfold higher, respectively, in DokR mice versus
the control mice (Fig. 7 B; unpublished data). However,
when leukocyte numbers were taken into account (Fig. 7 B),
we found that the absolute concentration of GFP
  monocytes
in DokR mice was similar to that in control mice (1.3  
Figure 6. Constitutive expression of DokR suppresses production 
of mature T cells but not mature B cells. (A) Flow cytometric analysis 
showing the percentage of GFP
  (top) and GFP
  (bottom) splenocytes 
expressing CD4 and CD8. The results shown are representative of 
data obtained from 7 to 13 mice per experimental group. (B) Flow 
cytometric analysis showing the expression of IgM and B220 on 
GFP
  (top) and GFP
  (bottom) splenocytes from reconstituted mice. 
The percentages of GFP
  and GFP
  B lymphocytes (IgM
 B220
  
cells) are indicated. Note that because of compensation for the high 
levels of fluorescence emitted by the GFP
  (B220
 IgM
 ) B cells, the 
DN (B220
 IgM
 ) population (bottom left) was partially obscured. 
Dot plots shown are representative of data pertaining to 7–13 mice 
per experimental group. Figure 7. Phenotypic analysis of myeloid lineages in the bone 
marrow and blood of reconstituted mice. (A) Flow cytometric 
analysis of bone marrow leukocytes from reconstituted control and 
DokR mice. Histograms show the percentage of GFP
  cells that 
express the myeloid lineage cell surface markers Mac-1 and Gr-1 
and the erythroid lineage marker Ter119. (B) Flow cytometric 
analysis of GFP
  blood leukocytes from control and DokR mice 
showing differential expression of Gr-1 and/or Mac-1. The numbers 
in each quadrant are percentages. The mean total leukocyte 
concentration   SEM (per ml of blood) is indicated above the dot 
plots (control mice, n   6; DokR mice, n   5).122 The Journal of Cell Biology | Volume 158, Number 1, 2002
0.5   10
6/ml vs. 1.9   0.4   10
6/ml, respectively) and the
concentration of neutrophils was slightly higher (2   10
6/ml
vs. 1.6   10
6/ml). Presumably, the reduced percentage of
GFP
  cells not expressing Gr-1 and Mac-1 in DokR mice
(Fig. 7 B) was due to a relative decrease in the representation
of cells of other lineages (e.g., T lymphoid cells). These re-
sults suggest that constitutive expression of DokR does not
significantly affect myeloid lineage development in vivo.
Expression of FLAG–DokR in T lymphoid, B lymphoid, 
and myeloid lineages
To examine the levels of FLAG–DokR protein in individual
hematopoietic lineages and to be sure that GFP levels re-
flected accurately the FLAG–DokR expression levels, we
pooled splenocytes from two control or two DokR mice and
sorted them into populations containing Thy-1
 , B220
 , or
Gr-1
 /Mac-1
  plus Gr-1
 /Mac-1
  populations (mature T
cells, B cells, and myeloid cells, respectively). Flow cytomet-
ric analysis confirmed that all cell populations were of a high
purity (85–97% pure; unpublished data). Cell lysates pre-
pared from each lineage were then analyzed by Western
blotting with anti-DokR antibodies. As shown in Fig. 8, en-
dogenous DokR was just detectable in T cells and myeloid
cells, but not in B cells from the control spleens, consistent
with its reported distribution (Nelms et al., 1998; Lemay et
al., 2000). Comparison of this expression pattern with that
in the DokR spleens clearly demonstrates that FLAG–DokR
was overexpressed in myeloid cells and B cells but, by con-
trast, was only slightly elevated compared with endogenous
DokR in splenic T cells. The levels of FLAG–DokR protein
closely matched the relative proportion of GFP
  cells in
each sample (values indicated below immunoblot). By con-
trast, the levels of RasGAP and Nck in each sample were
roughly equivalent. These results strongly support our con-
tention, based on GFP expression data, that DokR selec-
tively inhibits T cell development.
Discussion
DokR is expressed in several hematopoietic tissues (Di Cris-
tofano et al., 1998; Nelms et al., 1998; Lock et al., 1999;
Lemay et al., 2000; Grimm et al., 2001) and implicated in
cytokine and immunoreceptor signaling (Nelms et al., 1998;
Nemorin and Duplay, 2000; Suzu et al., 2000; Latour et al.,
2001), but its role in hematopoietic development is not
known. Using bone marrow reconstitution to study DokR
function in vivo, we found that DokR drastically inhibited
the ability of bone marrow cells to repopulate the thymi and
spleens of recipient mice. The efficiency with which cells re-
constituted the thymus appeared to be inversely related to
cellular DokR levels, suggesting that DokR inhibited thymic
reconstitution in a dose-dependent manner. Phenotypic
analysis of thymocytes and splenocytes derived from infected
(GFP
 ) precursors using T lineage markers showed that
DokR suppressed both thymocyte seeding and the progres-
sion of DN to DP thymocytes, leading to a marked deficit of
mature SP T cells in the thymus and, consequently, in the
spleen. In contrast to its inhibitory effects on T cell re-
population, DokR had only a modest inhibitory effect on
the ability of bone marrow cells to develop into mature
(IgM
 B220
 ) B cells and did not markedly affect the devel-
opment of myeloid lineages, such as neutrophils (Gr-1
 /
Mac-1
  cells) or monocytes (Gr-1
 /Mac-1
  cells) (see be-
low).
DokR partially inhibited the seeding of T cell precursors
in the thymus. This could be due to reduced expansion of
bone marrow–derived T cell precursors, leading to fewer
cells capable of repopulating the thymus. Alternatively, this
could be a consequence of an impaired homing capacity of
these precursors such that these cells develop normally but
fail to migrate to the thymus. At present we cannot distin-
guish between these two possibilities. We also detected a
marked inhibitory effect of DokR on T cell maturation
within the thymus. This effect was largely confined to a spe-
cific developmental checkpoint: the transition of primitive
CD4
 CD8
  DN thymocytes into immature CD4
 CD8
 
DP thymocytes (Fig. 4). Intriguingly, similar T cell matura-
tion defects occur in several null mutant mouse strains. Mice
lacking Lck (Molina et al., 1992), SLP-76 (Clements et al.,
1998; Pivniouk et al., 1998), linker of activated T cells
(LAT) (Zhang et al., 1999), Gads (Yoder et al., 2001), or
components of the pre-TCR complex (von Boehmer and
Fehling, 1997) show impaired thymocyte maturation beyond
the DN stage. All of these proteins appear to participate in a
common signaling pathway, initiated at the pre-TCR, and
controlling CD4
 CD8
  to CD4
 CD8
  thymocyte pro-
gression (von Boehmer and Fehling, 1997; Pivniouk and Geha,
2000; Tomlinson et al., 2000). The pre-TCR is thought to
trigger the activation of cytoplasmic protein tyrosine kinases,
Lck, Fyn, and Zap70, leading to the phosphorylation of
LAT and SLP-76, among other proteins (Pivniouk and
Geha, 2000; Tomlinson et al., 2000; Latour and Veillette,
2001). In turn, LAT and SLP-76 recruit several effector pro-
teins that together coordinate the activation of the Ras path-
way, mobilization of intracellular Ca
2  stores, and reorgani-
zation of the actin cytoskeleton (Pivniouk and Geha, 2000;
Figure 8. Reduced expression of FLAG–DokR in T cells relative to 
B cells and myeloid cells. B cells, T cells, and myeloid cells were 
purified from pooled splenocytes from two control or two DokR 
mice by using cell sorting to isolate B220
 , Thy-1
 , or Gr-1
 /Mac-1
  
plus Gr-1
 /Mac-1
  cells, respectively. The relative levels of expres-
sion of endogenous DokR and FLAG–DokR proteins in equivalent 
samples (5   10
4 cells) were determined by Western blot (WB) 
analysis of whole cell lysate (WCL) with an anti-DokR antibody. 
The blot was reprobed with anti-GAP and anti-Nck antibodies. The 
percentage of GFP
  cells in each sample is indicated.DokR negatively regulates T cell development | Gugasyan et al. 123
Tomlinson et al., 2000). Our results showing reduced DN
thymocyte progression indicate that DokR might negatively
regulate this signaling cascade. In support of this hypothesis,
Lck and Fyn are strongly implicated in signaling pathways
that control DokR tyrosine phosphorylation and its associa-
tion with RasGAP in T cell lines and primary thymocytes
(Nemorin and Duplay, 2000; Latour et al., 2001). More-
over, we showed that the RasGAP binding site of DokR
(Y276 and Y304) was essential for its inhibitory activity.
Thus, it is plausible that the reduced progression of
CD4
 CD8
  into CD4
 CD8
  thymocytes we observed is
mediated, at least in part, by RasGAP–DokR complexes that
facilitate inhibition of Ras signaling. However, our results
strongly argue that, in addition to recruitment of RasGAP,
binding of Nck (via Y351) is also critical for the inhibitory
function of DokR.
Nck is an adaptor protein that contains three SH3 do-
mains that bind a number of signaling proteins involved in
the regulation of actin cytoskeleton–dependent processes
such as membrane ruffling and axon guidance (Rivero-Lez-
cano et al., 1995; Bokoch et al., 1996; Galisteo et al., 1996;
Holland et al., 1997; Lu et al., 1997; Anton et al., 1998; Mc-
Carty, 1998). Interestingly, mutation of the Nck binding site
in p62
dok was found to suppress CHO cell migration in re-
sponse to insulin, implying that p62
dok-associated Nck also
regulates cell motility (Noguchi et al., 1999). Very recently,
interaction of DokR with Nck was shown to play a central
role in mediating endothelial cell motility in response to an-
giopoietin-1 (Master et al., 2001). It is tempting to speculate
that the migratory capacity of hematopoietic cells overex-
pressing DokR is also enhanced in an Nck-dependent man-
ner and, consequently, cell growth might be indirectly af-
fected, perhaps by altering exposure to growth stimulatory
signals. Recent studies on a novel mammalian Nck isoform,
Nck /Nck-2/Grb4 (Chen et al., 1998; Tu et al., 1998;
Coutinho et al., 2000), revealed that this protein can sup-
press growth factor–stimulated DNA synthesis (Chen et al.,
1998). It remains to be determined whether Nck /Nck-2/
Grb4 associates with DokR in hematopoietic cells and con-
tributes to its inhibitory activity. Mice deficient for both Nck
isoforms have been generated recently, and although cells
from these mice are resistant to actin cytoskeletal remodel-
ling induced by the Tir protein of a pathogenic form of Esch-
erichia coli, EPEC (Gruenheid et al., 2001), cell growth de-
fects have not been reported. Irrespective of such a role, our
results showing that the DokR Y276/304F mutant (which
contains a functional Nck binding site) had little or no effect
on T cell maturation or progenitor cell growth suggest that
binding to Nck alone is insufficient for DokR to exert its ef-
fects. On this basis, we propose that DokR, Nck, and Ras-
GAP might cooperate to negatively regulate cell growth.
In a previous study, DokR suppression of M-CSF– and
SCF-dependent proliferation of NFS-60 leukemia cells was
described (Suzu et al., 2000). We have extended these stud-
ies by demonstrating that DokR can also inhibit colony for-
mation of primary hematopoietic cells, namely bone mar-
row–derived myeloid progenitor cells, in the presence of
M-CSF and SCF. In addition, we have demonstrated a re-
quirement for both Nck and RasGAP binding sites for this
activity. Given the ability of DokR to suppress colony for-
mation in the presence of cytokines such as M-CSF, we pre-
dicted that it might also negatively regulate the generation of
myeloid lineages in vivo. However, our studies did not pro-
vide evidence for DokR in this role. Although we were sur-
prised by these results, it is possible that other signaling
pathways that cannot be inhibited by DokR have a greater
role in the generation of these myeloid cell lineages in vivo.
For example, IL-3– and GM-CSF–dependent colony forma-
tion in vitro was only mildly inhibited by expression of
DokR and, therefore, their ability to regulate the generation
of myeloid cells in vivo would probably also be unaffected.
As yet, DokR-deficient mice generated by gene targeting
have not been reported. However, two groups have created
p62
dok /  mice, and although studies on these animals have
not revealed any effects on hematopoietic development, sev-
eral hematopoietic cell types exhibit defects in negative regula-
tion of proliferation in vitro (Yamanashi et al., 2000; Di Cris-
tofano et al., 2001). For example, p62
dok /  B cells are
hyperresponsive to cross-linking of the B cell antigen receptor
and the inhibitory receptor Fc RIIB (Yamanashi et al., 2000).
In addition, thymocytes costimulated with concanavalin A
and IL-2 and bone marrow cells stimulated with SCF or IL-3
show enhanced responsiveness to these treatments compared
with normal cells (Di Cristofano et al., 2001). Interestingly,
loss of p62
dok also enhanced the rate at which bone marrow
expressing the Bcr-Abl oncoprotein can induce a lethal my-
eloid leukemia in reconstituted mice (Di Cristofano et al.,
2001). At a molecular level, p62
dok /  cells show sustained ac-
tivation of Ras- and mitogen-activated protein kinases in re-
sponse to various stimuli (Yamanashi et al., 2000; Di Cristo-
fano et al., 2001), presumably at least partly due to reduced
RasGAP-mediated attenuation of Ras signaling. Given that
p62
dok and DokR are both capable of recruiting RasGAP and
Nck and are expressed simultaneously in many hematopoietic
cell types (except B cells, which lack DokR), it is possible that
these proteins are functionally redundant. We cannot rule out
the possibility that some of the effects we observed here
would, under physiological conditions, be mediated by p62
dok
and are simply a consequence of overexpressing a Dok protein
in cells. It is also likely that DokR and p62
dok have unique
functions. It is particularly interesting in this respect that al-
though p62
dok /  bone marrow cells showed dramatically en-
hanced IL-3 signaling in vitro, overexpression of DokR in
bone marrow cells had very little effect on IL-3–dependent
colony formation in our hands. The question of functional re-
dundancy will only be clearly resolved when mice deficient for
both p62
dok and DokR are generated and analyzed.
In summary, we have examined the role of DokR in regulat-
ing haematopoiesis. Our results provide compelling evidence
for DokR-mediated negative regulation of T cell development
and suggest that both RasGAP and Nck, through interaction
with DokR at distinct sites, are critical for DokR function.
Materials and methods
Construction and characterization of retroviral constructs
Complementary DNAs encoding wild-type and mutant forms of FLAG–
DokR (Lock et al., 1999) were inserted into the retroviral plasmid, pMY-
EGFP (Onai et al., 2000). Bosc23 virus packaging cells (Pear et al., 1993)
were transfected with pMY-DokR-EGFP constructs as previously described
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after transfection, adjusted to 10 mM Hepes, pH 7.0, and stored at  70 C.
The infectious titres of frozen viral stocks were determined as previously
described (Cong et al., 1999). Titres of between 1 and 2   10
6 infectious
units/ml were routinely observed for each retroviral construct. To confirm
the binding specificity of DokR mutants, 293T cells were cotransfected
with pMY-DokR-EGFP constructs encoding Y351F or Y276/304F together
with an expression vector encoding Lyn. Cell extracts were analyzed as
described previously (Lock et al., 1999).
Retrovirus-mediated infection of bone marrow cells
Permission to use mice for this research was obtained from the animal eth-
ics committee of the Ludwig Institute for Cancer Research and Department
of Surgery, University of Melbourne. A spin infection procedure was used
to infect bone marrow cells (van Parijs et al., 1999). In brief, bone marrow
cells were harvested from the femurs of 8-wk-old female C57BL/6 mice 4 d
after intravenous injection with 3.75 mg of 5-fluorouracil. RBCs were lysed
in RBC lysis buffer (17 mM Tris-HCl, pH 7.65, 144 mM NH4Cl) for 5 min
at 37 C. Washed leukocytes were resuspended at a density of 2   10
6
cells/ml in growth medium (DME medium supplemented with 15% FCS, 2
mM glutamine, 10% WEHI-3B cell-conditioned medium, 50 ng/ml murine
SCF [a gift from N. Nicola, Walter and Eliza Hall Institute of Medical Re-
search], 10 ng/ml human IL-3 [PeproTech], and 50 ng/ml murine IL-6 [a
gift from R. Moritz, Ludwig Institute for Cancer Research, Parkville, Austra-
lia]) in 24-well plates (Nunc) and cultured for 3 h in 10% CO2 at 37 C.
Growth medium was removed from the cells and replaced with retroviral
supernatants containing equivalent numbers of infectious retroviruses (see
above) and 4  g/ml polybrene (Sigma-Aldrich). Plates were then centri-
fuged at 1,200 rpm at 37 C for 45 min (4K15 centrifuge; Sigma-Aldrich).
Cells were replenished with growth medium, cultured overnight, and in-
fected again 24, 48, and 72 h later.
Cytospin analysis of retrovirally infected bone marrow cells
Day 7 cultures of bone marrow cells infected in vitro with control, DokR,
and DokR mutant retroviruses were deposited onto microscope slides at
800 rpm for 5 min at RT, stained with May-Grunwald Giemsa (Sigma-
Aldrich), and mounted with DePeX (BDH). Cells were identified micro-
scopically based on morphology, and the percentage of an individual cell
type was calculated based on the analysis of 200 cells.
In vitro colony formation assays
Retrovirally infected bone marrow cells were washed in PBS containing
1% FCS and then cultured in 0.3% agar containing DME, 20% FCS, and
the following cytokines: M-CSF (10 ng/ml); SCF (50 ng/ml); GM-CSF (10
ng/ml); or IL-3 (10 ng/ml). For M-CSF and SCF cultures, 5,000 cells were
plated per 35-mm dish. For GM-CSF and IL-3 cultures, 2,000 and 1,000
cells were plated per dish, respectively. Colonies of  50 GFP
  cells were
scored by fluorescence microscopy after 7 d. Assays were performed in
quadruplicate three times.
Bone marrow reconstitution experiments
Female C57BL/6 mice were   irradiated (two doses of 550 rads, 3 h apart)
and injected intravenously with 2–5   10
5 retrovirally infected bone mar-
row cells. Mice were administered the antibiotic Baytril (Bayer) (0.17 mg/
ml) in their drinking water and housed in microisolators. Mice were killed
10 wk after bone marrow reconstitution and the spleens, thymi, and bone
marrow were dissected.
Preparation of hematopoietic cells from reconstituted mice
Bone marrow cells were flushed from the femurs of reconstituted mice in 5
ml of FACS buffer (PBS containing 1% FCS). Suspensions of splenocytes and
thymocytes were prepared by gently teasing spleens and thymi respectively
through a stainless steel mesh in 5 ml of FACS buffer. Blood was obtained by
eye bleeding. Crude cell suspensions were depleted of RBCs by one or two
incubations in RBC lysis buffer at RT or 37 C and then washed two times in
FACS buffer. Numbers of viable leukocytes from spleen, thymus, and bone
marrow were determined on the basis of eosin exclusion using a hemocy-
tometer. For absolute blood leukocyte counts, 5  l of heparinized blood
was diluted in 20 ml PBS buffer containing 1% Zap-oglobin lytic reagent
(Beckman Coulter) for lysis of RBCs. The cells were then counted using a
particle count and size analyzer (counter model Z2; Beckman Coulter).
Flow cytometry
Flow cytometric analyses were performed using a FACScan
® flow cytome-
ter and CellQuest software (Becton Dickinson). Leukocytes were resus-
pended at a density of 20   10
6 cells/ml in FACS buffer. Cells were then
either analyzed for GFP expression immediately, or, for two- and three-
color analyses, stained with phycoerythrin (PE)-conjugated monoclonal
antibodies (anti-CD8, anti-B220, anti–Gr-1, anti–Mac-1; BD PharMingen)
and/or biotinylated monoclonal antibodies (anti-CD4, anti-IgM, anti-cKit,
anti-Ter119) for 30 min at 4 C. For detection of biotinylated antibodies,
cells were stained with streptavidin-PE (Caltag) or streptavidin-tricolor
(Caltag) where appropriate for 30 min at 4 C. For one- and two-color anal-
yses, cells were washed and resuspended in FACS buffer containing 2  g/
ml propidium iodide (PI) to exclude nonviable cells. For three-color analy-
ses, 20  g/ml PI was added to distinguish PI-positive from tricolor-positive
cells, as both are in the FL-3 channel. Cell viability was generally  90%.
Residual RBCs were excluded from all analyses on the basis of forward
scatter. Antibodies were provided by A. Strasser (Walter and Eliza Hall In-
stitute of Medical Research), M. Hibbs, and S. Basu (Ludwig Institute for
Cancer Research) unless otherwise indicated.
Cell sorting
Cells were sorted using a MoFlo cell sorter (Cytomation, Inc.). For purifi-
cation of splenic B cells, T cells, and myeloid cells, splenocytes from two
control mice or two DokR mice were pooled, resuspended in 0. 5 ml of
balanced salt solution (BSS) (149 mM NaCl, 3.7 mM KCl, 2.5 mM CaCl2,
1.2 mM MgSO4, 2.5 mM potassium phosphate, 14.8 mM Hepes, pH 7.2)
containing 4% FCS (BSS/FCS) and divided into two equal fractions. Cells
were then stained either with anti–B220-PE plus anti–Thy-1 biotin or
with anti–Mac-1–PE plus anti–Gr-1 biotin. Cells were incubated for 30
min at 4 C, washed in BSS/FCS, collected by centrifugation, and incu-
bated with streptavidin-tricolor (Caltag) for 30 min at 4 C. Cells were
washed as above and then separated from cell clumps using a cell debris
removal column. Cells were resuspended in BSS/FCS containing excess
PI (20  g/ml) to distinguish between tricolor and PI-positive populations.
Cells were then sorted into B220
  (B lymphoid), Thy-1
  (T lymphoid), or
Gr-1
 /Mac-1
  plus Gr-1
 /Mac-1
  (myeloid) populations. Only PI-nega-
tive cells were included in the sorted populations. For purification of
primitive thymic T cells, thymocytes from individual control or DokR
mice were resuspended in 0.25 ml BSS/FCS, stained with a cocktail of
PE-coupled (anti-CD8, anti-B220, anti–Gr-1, anti–Mac-1) and biotinyl-
ated antibodies (anti-CD4, MHC class II) for 30 min at 4 C, washed, and
then stained with streptavidin-PE. Cells were washed and resuspended in
BSS/FCS containing PI as above, and cells that did not stain with PE or PI
were collected by cell sorting.
Immunoprecipitation and immunoblot analysis
Splenocyte and thymocyte extracts were prepared by lysing cells in lysis
buffer (50 mM Tris, pH 8.0, 1% Triton X-100, 150 mM NaCl) supple-
mented with a cocktail of protease inhibitors (complete; Roche) for 15 min
at 4 C. Extracts of purified splenic T cells, B cells, and myeloid cells were
prepared by washing cells once in ice cold TBS containing a twofold ex-
cess of protease inhibitors before extraction in lysis buffer as above. Cell
lysates were clarified by centrifugation at 13,000 rpm for 15 min at 4 C.
Splenocyte and thymocyte extracts containing  1   10
6 cells were ana-
lyzed by immunoprecipitation with anti-FLAG sepharose beads (Sigma-
Aldrich), followed by SDS-PAGE and Western analysis using an anti-DokR
serum (Lock et al., 1999). Lysates containing 5   10
4 splenic B cells, T
cells, or myeloid cells were analyzed sequentially by Western blotting
with anti-DokR, anti-GAP, and anti-Nck sera.
Statistical analyses
An unpaired t test was performed to compare the arithmetic means   SEM
of values relating to the control group of reconstituted mice with those per-
taining to the DokR, Y351F, or Y276/304F mice.
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